These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 16320253)

  • 1. Nurr1 in Parkinson's disease and related disorders.
    Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
    J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
    Chu Y; Kompoliti K; Cochran EJ; Mufson EJ; Kordower JH
    J Comp Neurol; 2002 Aug; 450(3):203-14. PubMed ID: 12209851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.
    Alladi PA; Mahadevan A; Yasha TC; Raju TR; Shankar SK; Muthane U
    Neuroscience; 2009 Mar; 159(1):236-45. PubMed ID: 19135503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation.
    Witta J; Baffi JS; Palkovits M; Mezey E; Castillo SO; Nikodem VM
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):67-78. PubMed ID: 11113533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.
    Jankovic J; Chen S; Le WD
    Prog Neurobiol; 2005; 77(1-2):128-38. PubMed ID: 16243425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
    von Bohlen und Halbach O; Minichiello L; Unsicker K
    FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIP is a transcriptional target of Nurr1 in dopaminergic cells.
    Luo Y; Henricksen LA; Giuliano RE; Prifti L; Callahan LM; Federoff HJ
    Exp Neurol; 2007 Jan; 203(1):221-32. PubMed ID: 16999955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system.
    Zetterström RH; Williams R; Perlmann T; Olson L
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):111-20. PubMed ID: 8883941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
    J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
    Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
    Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
    Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
    Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury.
    Le W; Conneely OM; He Y; Jankovic J; Appel SH
    J Neurochem; 1999 Nov; 73(5):2218-21. PubMed ID: 10537083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
    Vuillermot S; Feldon J; Meyer U
    Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of tyrosine hydroxylase-immunoreactive neurons in ventral mesencephalic tissue of Nurr1 deficient mice.
    Tornqvist N; Hermanson E; Perlmann T; Stromberg I
    Brain Res Dev Brain Res; 2002 Jan; 133(1):37-47. PubMed ID: 11850062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo.
    Pan T; Zhu W; Zhao H; Deng H; Xie W; Jankovic J; Le W
    Brain Res; 2008 Jul; 1222():222-9. PubMed ID: 18579122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.